E
Eluciderm develops a topical formulation that promotes scarless wound healing by minimizing dermal fibrosis through targeted delivery of active compounds. This product addresses the challenge of excessive scarring in wound recovery, enhancing patient outcomes and skin integrity.
Updated 4 months ago
Funding
$7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Eluciderm develops a topical formulation that promotes scarless wound healing by minimizing dermal fibrosis through targeted delivery of active compounds. This product addresses the challenge of excessive scarring in wound recovery, enhancing patient outcomes and skin integrity.